Want to see more of NewsNation? Get 24/7 fact-based news coverage with the NewsNation app or add NewsNation as a preferred source on Google !

( NewsNation ) — A new study has found evidence linking the use of GLP-1 medications like Ozempic and Wegovy to lower death rates in colon cancer patients.

The University of California, San Diego study examined data from more than 6,800 colon cancer patients. It took into account patients’ ages, Body Mass Index scores, cancer severity and other health conditions. It found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor agonists, 15.5% vs 37.1%.

According to the study, the survival benefit appeared most pronounced in patients with BMI scores over 35. The university n

See Full Page